Literature DB >> 18545940

Citalopram-associated central retinal vein occlusion.

Alastair D Hardisty1, Christopher M Hemmerdinger, Say Aun Quah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18545940     DOI： 10.1007/s10792-008-9231-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN： 0165-5701            Impact factor:   2.031


× No keyword cloud information.
  5 in total

Review 1.  Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.

Authors:  S M Stahl
Journal:  J Affect Disord       Date:  1998-12       Impact factor: 4.839

Review 2.  Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.

Authors:  B P Skop; T M Brown
Journal:  Psychosomatics       Date:  1996 Jan-Feb       Impact factor: 2.386

3.  Venous thromboembolism and escitalopram.

Authors:  Asli Kurne; Aygun Ertugrul; A Elif Anil Yağcioğlu; Kazim M Yazici
Journal:  Gen Hosp Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.238

4.  Selective serotonin reuptake inhibitors and myocardial infarction.

Authors:  W H Sauer; J A Berlin; S E Kimmel
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

5.  Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics.

Authors:  S S Hayreh; M B Zimmerman; P Podhajsky
Journal:  Am J Ophthalmol       Date:  1994-04-15       Impact factor: 5.258
  5 in total
  1 in total

1.  SSRI-associated optic neuropathy.

Authors:  J Lochhead
Journal:  Eye (Lond)       Date:  2015-07-03       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.